Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
The Open Infectious Diseases Journal, 2010, 4, 33-37
Reprinted from Australian Family Physician Vol. 39, No. 10, october 2010
Submitted to The Lesotho National Federation of Disabled (LNFOD)
Program Report for Collaborative Agreement: DFD-A-00-08-00309-00 September 30, 2008 -December 31, 2015
This progress report reflects achievements made during the first year of implementation (through December 2016), as countries have taken actions in line with new or existing national strategies. The most recent data on country progress in 2016 are based on country-reported data and country-developed... models using Spectrum software that were reported to UNAIDS in 2017.
more
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...ry – the two key institutions to ensure the quality, safety, and efficacy of medicines. The MOH Pharmacy Taskforce (PTF) is to be commended however for successfully controlling the pharmaceutical market to the extent that there is no informal medicines market in Rwanda. Based on its findings, the assessment team expects Rwanda to be able to make great strides in evidence-based medicines quality assurance in the short to medium term, provided it receives adequate technical assistance and financial support.
more